The pharma industry is focused on strengthening its foundation, embracing innovation, and future-proofing its path forward.

Major pharmaceutical companies are committing billions to US manufacturing in an effort to avoid steep tariffs threatened by ...

Biotechs such as Gilead (NASDAQ:GILD) and Vertex Pharma (NASDAQ:VRTX), with a high local tax bill, a heavy U.S.-based ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...

Drug prices are out-of-control. U.S. citizens pay higher prices than almost anywhere else in the world despite the fact that ...

Interor, a European player in pharmaceutical intermediates and specialty chemicals, is eyeing India for its next phase of growth. CEO Geoffroy Waroqueaux shares insights on potential investment, ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Here's a list of the companies that have announced new U.S. investments since Trump took office: Merck on Tuesday said it is ...

Samsung Biologics, which has enjoyed a booming contract drug manufacturing streak over the past year, has inked another ...

Merck is particularly exposed to the tariff threat, as much of its production of Keytruda takes place at facilities in ...